Hoogerbrugge N - Search Results

1

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.

Gómez García EB, Oosterwijk JC, Timmermans M, van Asperen CJ, Hogervorst FB, Hoogerbrugge N, Oldenburg R, Verhoef S, Dommering CJ, Ausems MG, van Os TA, van der Hout AH, Ligtenberg M, van den Ouweland A, van der Luijt RB, Wijnen JT, Gille JJ, Lindsey PJ, Devilee P, Blok MJ, Vreeswijk MP. Gómez García EB, et al. Among authors: hoogerbrugge n. Breast Cancer Res. 2009;11(1):R8. doi: 10.1186/bcr2223. Epub 2009 Feb 6. Breast Cancer Res. 2009. PMID: 19200354 Free PMC article.

2

High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.

Hoogerbrugge N, Bult P, de Widt-Levert LM, Beex LV, Kiemeney LA, Ligtenberg MJ, Massuger LF, Boetes C, Manders P, Brunner HG. Hoogerbrugge N, et al. J Clin Oncol. 2003 Jan 1;21(1):41-5. doi: 10.1200/JCO.2003.02.137. J Clin Oncol. 2003. PMID: 12506168 Free article.

3

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: hoogerbrugge n. Cancer Res. 2003 Dec 1;63(23):8153-7. Cancer Res. 2003. PMID: 14678969

4

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.

van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WA. van Roosmalen MS, et al. Among authors: hoogerbrugge n. Br J Cancer. 2004 Jan 26;90(2):333-42. doi: 10.1038/sj.bjc.6601525. Br J Cancer. 2004. PMID: 14735173 Free PMC article. Clinical Trial.

5

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.

van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WA. van Roosmalen MS, et al. Among authors: hoogerbrugge n. Am J Med Genet A. 2004 Feb 1;124A(4):346-55. doi: 10.1002/ajmg.a.20374. Am J Med Genet A. 2004. PMID: 14735581 Free article.

6

Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis.

Kievit W, de Bruin JH, Adang EM, Ligtenberg MJ, Nagengast FM, van Krieken JH, Hoogerbrugge N. Kievit W, et al. Among authors: hoogerbrugge n. Clin Genet. 2004 Apr;65(4):308-16. doi: 10.1111/j.1399-0004.2004.00220.x. Clin Genet. 2004. PMID: 15025724

7

More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon.

van den Bos M, van den Hoven M, Jongejan E, van der Leij F, Michels M, Schakenraad S, Aben K, Hoogerbrugge N, Ligtenberg M, van Krieken JH. van den Bos M, et al. Among authors: hoogerbrugge n. Am J Surg Pathol. 2004 Jun;28(6):706-11. doi: 10.1097/01.pas.0000126720.49083.11. Am J Surg Pathol. 2004. PMID: 15166662

8

Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.

van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WA. van Roosmalen MS, et al. Among authors: hoogerbrugge n. J Clin Oncol. 2004 Aug 15;22(16):3293-301. doi: 10.1200/JCO.2004.05.066. J Clin Oncol. 2004. PMID: 15310772 Free article. Clinical Trial.

9

[Recognising hereditary non-polyposis colorectal cancer without a clear family history].

de Bruin JH, Nagengast FM, Ligtenberg MJ, van Krieken JH, Niermeijer MF, Hoogerbrugge N. de Bruin JH, et al. Among authors: hoogerbrugge n. Ned Tijdschr Geneeskd. 2004 Oct 16;148(42):2053-7. Ned Tijdschr Geneeskd. 2004. PMID: 15532325 Dutch.

10

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.

Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A, Leenders EP, Wesseling J, de Hullu J, Hoogerbrugge N, Ligtenberg MJ, Ardern-Jones A, Bancroft E, Salmon A, Barwell J, Eeles R, Oosterwijk JC. Leegte B, et al. Among authors: hoogerbrugge n. J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243. J Med Genet. 2005. PMID: 15744030 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page